Literature DB >> 10408361

Modular organization of proteins containing C1q-like globular domain.

U Kishore1, K B Reid.   

Abstract

The first step in the activation of the classical pathway of complement cascade by immune complexes involves the binding of the six globular heads of C1q to the Fc regions of immunoglobulin G (IgG) or immunoglobulin M (IgM). The globular heads of C1q are located C-terminal to the six triple-helical stalks present in the molecule, each head is considered to be composed of the C-terminal halves (3 x 135 residues) of one A-, one B- and one C-chain. It is not known if the C-terminal globular regions, present in each of the three types of chains, are independently folded modules (with each chain having distinct binding properties towards immunoglobulins) or whether the different binding functions of C1q are dependent upon a globular structure which relies on contributions from all three chains. Recent reports of recombinant production and characterisation of soluble globular head regions of all the three chains indicate that the globular regions of C1q may adopt a modular organization, i.e., each globular head of C1q may be composed of three, structurally and functionally, independent domains, thus retaining multivalency in the form of a heterotrimer. Modules of the same type as the C1q C-terminal module are also found in a variety of noncomplement proteins that include the C-terminal regions of the human type VIII and type X collagens, precerebellin, the chipmunk hibernation proteins, the human endothelial cell protein, multimerin, the serum protein, Acrp-30 which is secreted from mouse adipocytes, and the sunfish inner-ear specific structural protein. The C1q molecule is the only one of these proteins for which, to date, a function has been ascribed to the module. The existence of a shared structural region between C1q and certain collagens may suggest an evolutionarily common ancestral precursor. Various structural and biochemical data suggest that these modules may be responsible for multimerisation through patches of aromatic residues within them.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408361     DOI: 10.1016/s0162-3109(99)00011-9

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  25 in total

1.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

3.  Molecular analysis of the magnocellular neuroendocrine phenotype: from the micropunch to laser microdissection.

Authors:  Noriko Mutsuga; Harold Gainer
Journal:  Neurochem Res       Date:  2006-03-30       Impact factor: 3.996

4.  Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Authors:  Geoffrey W Stone; Suzanne Barzee; Victoria Snarsky; Kristin Kee; Celsa A Spina; Xiao-Fang Yu; Richard S Kornbluth
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.

Authors:  Hee Young Hwang; Marcus R Duvall; Stephen Tomlinson; Robert J Boackle
Journal:  Mol Immunol       Date:  2008-03-03       Impact factor: 4.407

6.  CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.

Authors:  Suefen Kwa; Lilin Lai; Sailaja Gangadhara; Mariam Siddiqui; Vinod B Pillai; Celia Labranche; Tianwei Yu; Bernard Moss; David C Montefiori; Harriet L Robinson; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

7.  Microarray analysis of gene expression in the supraoptic nucleus of normoosmotic and hypoosmotic rats.

Authors:  Chunmei Yue; Noriko Mutsuga; Joseph Verbalis; Harold Gainer
Journal:  Cell Mol Neurobiol       Date:  2006-05-13       Impact factor: 5.046

8.  Direct detection of collagenous proteins by fluorescently labeled collagen mimetic peptides.

Authors:  Yang Li; Daniel Ho; Huan Meng; Tania R Chan; Bo An; Hanry Yu; Barbara Brodsky; Albert S Jun; S Michael Yu
Journal:  Bioconjug Chem       Date:  2013-01-03       Impact factor: 4.774

9.  Identification of immune-relevant genes from atlantic salmon using suppression subtractive hybridization.

Authors:  S C M Tsoi; K V Ewart; S Penny; K Melville; R S Liebscher; L L Brown; S E Douglas
Journal:  Mar Biotechnol (NY)       Date:  2004-04-29       Impact factor: 3.619

Review 10.  Mechanisms of otoconia and otolith development.

Authors:  Yunxia Wang Lundberg; Yinfang Xu; Kevin D Thiessen; Kenneth L Kramer
Journal:  Dev Dyn       Date:  2014-10-18       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.